CBI’s 4th Annual Life Sciences Compliance Congress for Specialty Products

September 13, 2018 – September 14, 2018 Boston, MA

CBI’s Compliance Congress for Specialty Products serves as the life sciences industry’s only conference catered to the unique compliance challenges for specialty bio/pharmaceutical companies, pre- and post-commercialization. This conference offers proactive strategies for managing risks in patient support services, specialty pharmacy contracting and government price reporting. 

To learn more, click here

"Shed Light on Regulatory and Compliance Concerns for Specialty Pharmacy Distribution"
Day 1 - September 13 @ 3:30 pm


Michelle D. Axelrod
Principal, Porzio, Bromberg & Newman, PC;
Vice President, Porzio Life Sciences, LLC

Rupa Cornell
Senior Director, Legal
SAGE Therapeutics

"Explore the Trends in Drug Pricing Legislation and Other State Initiatives"
Day 2 - September 14 @ 9:15 am


John P. Oroho
Executive Vice President & Chief Strategy Officer
Porzio Life Sciences, LLC


37 Ex-US Jurisdictions Served

4 Offices

370 Companies Served

Questions? Request more information or call 973-538-1690

Contact Us